Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.
about
Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapyAdaptive Landscape by Environment Interactions Dictate Evolutionary Dynamics in Models of Drug ResistanceTackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host.Multidrug evolutionary strategies to reverse antibiotic resistance.Modeling Invasion Dynamics with Spatial Random-Fitness Due to Micro-EnvironmentEvolution of coreceptor utilization to escape CCR5 antagonist therapy.A Two-Locus Model of the Evolution of Insecticide Resistance to Inform and Optimise Public Health Insecticide Deployment StrategiesHow to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogensEvolutionary scalpels for dissecting tumor ecosystems.Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies.Visualizing evolution as it happens.Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.Modeling Kick-Kill Strategies toward HIV Cure.Strain Diversity and the Evolution of Antibiotic Resistance.Increased T cell trafficking as adjunct therapy for HIV-1.Tuning Spatial Profiles of Selection Pressure to Modulate the Evolution of Drug Resistance.Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosisSanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments
P2860
Q28544732-55E61643-D202-419D-863A-724330B80906Q28552806-81F88221-22F3-44A9-AD1B-432FF964B27CQ30393531-E5103FC0-503A-4C25-9561-76B4705B1D48Q33576860-AF067213-AB1B-473A-A335-39CE24D6A506Q33728690-800B01D4-71FB-42F4-97A9-A84A46CBF8ACQ33871101-1EE38FDD-E956-42F9-82FA-E590712B4FFEQ35824179-01B9E003-5EE1-4681-B003-443DA6C97897Q36003168-C728E0FD-1E55-40D3-8956-A8CA9BA824D6Q36251131-355D5C11-0642-44A6-A385-DB56BE64C60BQ36275612-6077F13A-1D19-4E5A-BC9C-C27925FC6E4FQ36610081-0FAA66D8-28ED-41EC-B8DE-FAF8983DA1BFQ37090265-12047984-ABF5-4906-B1E3-EFA999F4D40AQ39030938-776AF713-EE06-4ADE-A9F5-9F6D67D4749FQ39038482-5A3C81AD-288C-45F0-B6F6-66019018E6E6Q40043861-C86626AE-7D14-4347-9D37-2CC3C2EDDF90Q40546180-E68A8776-EB28-4C39-AA53-7801808D04A9Q42358813-DC6F6C61-155B-4387-B7E6-BBBC008232D3Q47098032-EDF74E85-9050-4E0D-A5AE-85EC9CB9811FQ47851713-C5CAC6A7-DF2B-4947-A706-AB1E867EE685Q52677071-40902463-8B44-4047-A3FB-460B12C95EF7Q55484794-FF92CC39-E434-4BAB-932B-58E6C2BA9428Q56828266-4371190C-AAE8-48A9-9AA7-955C34DD6408Q58792426-83E8328E-198D-49AE-AEB7-967E88EDF3B8
P2860
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Imperfect drug penetration lea ...... ution of multidrug resistance.
@ast
Imperfect drug penetration lea ...... ution of multidrug resistance.
@en
type
label
Imperfect drug penetration lea ...... ution of multidrug resistance.
@ast
Imperfect drug penetration lea ...... ution of multidrug resistance.
@en
prefLabel
Imperfect drug penetration lea ...... ution of multidrug resistance.
@ast
Imperfect drug penetration lea ...... ution of multidrug resistance.
@en
P2093
P2860
P50
P356
P1476
Imperfect drug penetration lea ...... ution of multidrug resistance.
@en
P2093
Alison L Hill
Martin A Nowak
Stefany Moreno-Gamez
P2860
P304
P356
10.1073/PNAS.1424184112
P407
P577
2015-05-18T00:00:00Z